Sponsor pipeline

ReCode Therapeutics clinical trial pipeline

Get alerts when ReCode Therapeutics's trials change

2 active trials 0 recruiting 1 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-20
Enrollment reduced: 192 → 128 participants
Enrollment closed, study ongoing
Primary completion pushed: 2026-08-30 → 2026-11
Completion moved earlier: 2026-12-31 → 2026-11
NCT06237335 A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy… · Phase 2

Active trials by phase

Phase 2
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06237335 A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy… Cystic Fibrosis Active, Not Recruiting 2026-08-19
Not specified
NCT06172374 A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia… Primary Ciliary Dyskinesia Active, Not Recruiting 2025-05-11

Disease areas by active trials

Cystic Fibrosis (1)

Get alerts when ReCode Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free